Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,856 | 631 | 98.8% |
| Education | $69.95 | 1 | 0.7% |
| Grant | $45.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,521 | 171 | $0 (2024) |
| Allergan, Inc. | $2,130 | 165 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $762.95 | 62 | $0 (2024) |
| Galderma Laboratories, L.P. | $567.19 | 43 | $0 (2024) |
| PFIZER INC. | $529.53 | 32 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $451.36 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $420.02 | 19 | $0 (2024) |
| MAYNE PHARMA INC. | $334.18 | 14 | $0 (2022) |
| MERZ NORTH AMERICA, INC. | $309.34 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $278.06 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,772 | 102 | ABBVIE INC. ($832.01) |
| 2023 | $1,607 | 92 | AbbVie Inc. ($828.28) |
| 2022 | $1,666 | 101 | Allergan, Inc. ($727.75) |
| 2021 | $671.21 | 49 | Allergan, Inc. ($391.88) |
| 2020 | $480.54 | 35 | Allergan, Inc. ($364.74) |
| 2019 | $1,391 | 115 | Allergan Inc. ($350.50) |
| 2018 | $1,357 | 68 | Allergan Inc. ($270.75) |
| 2017 | $1,027 | 71 | Galderma Laboratories, L.P. ($192.21) |
All Payment Transactions
633 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Immunology | ||||||
| 11/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $34.93 | General |
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $0.91 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/23/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $34.12 | General |
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.68 | General |
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $4.90 | General |
| 10/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Immunology | ||||||
| 10/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/09/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $22.39 | General |
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $18.15 | General |
| 09/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: DERMATOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: FACIAL AESTHETICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,375 | 3,624 | $598,446 | $172,055 |
| 2022 | 18 | 2,169 | 3,514 | $537,970 | $157,823 |
| 2021 | 16 | 1,622 | 2,668 | $407,670 | $122,225 |
| 2020 | 17 | 1,600 | 2,523 | $364,998 | $103,938 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 617 | 791 | $130,284 | $48,562 | 37.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 314 | 403 | $111,228 | $32,821 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 313 | 397 | $95,274 | $31,447 | 33.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 209 | 243 | $63,180 | $14,940 | 23.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 265 | 335 | $69,680 | $11,843 | 17.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 142 | 154 | $16,324 | $6,403 | 39.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 183 | 813 | $32,520 | $4,056 | 12.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 18 | 26 | $12,362 | $3,226 | 26.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $8,600 | $2,651 | 30.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 55 | 72 | $11,210 | $2,545 | 22.7% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 26 | 56 | $10,390 | $2,529 | 24.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 23 | 25 | $8,125 | $2,419 | 29.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 15 | $6,255 | $2,184 | 34.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 41 | 51 | $7,650 | $2,049 | 26.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 18 | 18 | $5,760 | $1,848 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,090 | $1,220 | 29.8% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 11 | 12 | $3,864 | $1,184 | 30.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 77 | 165 | $1,650 | $129.39 | 7.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 557 | 746 | $119,195 | $44,009 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 271 | 355 | $79,849 | $31,679 | 39.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 246 | 326 | $89,976 | $26,020 | 28.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 207 | 230 | $59,800 | $14,400 | 24.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 259 | 340 | $70,468 | $12,865 | 18.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 122 | 139 | $14,734 | $5,789 | 39.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 164 | 814 | $32,405 | $4,327 | 13.4% |
About Dr. Sylvia Wright, M.D
Dr. Sylvia Wright, M.D is a Specialist healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578526836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sylvia Wright, M.D has received a total of $9,971 in payments from pharmaceutical and medical device companies, with $1,772 received in 2024. These payments were reported across 633 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($9,856).
As a Medicare-enrolled provider, Wright has provided services to 7,766 Medicare beneficiaries, totaling 12,329 services with total Medicare billing of $556,041. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Atlanta, GA
- Active Since 04/08/2006
- Last Updated 03/04/2019
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1578526836
Products in Payments
- RINVOQ (Biological) $687.80
- BOTOX (Biological) $578.17
- SKYRIZI (Biological) $565.05
- EUCRISA (Drug) $513.74
- DUPIXENT (Biological) $445.76
- BOTOX COSMETIC (Biological) $444.09
- Humira (Biological) $429.21
- COSENTYX (Biological) $386.27
- DORYX (Drug) $302.46
- Sotyktu (Drug) $278.06
- Tremfya (Drug) $226.88
- COSENTYX (Drug) $197.92
- SOOLANTRA (Drug) $171.11
- DUPIXENT DUPILUMAB INJECTION (Biological) $164.70
- VTAMA (Drug) $164.40
- ADBRY (Biological) $142.33
- KYBELLA (Biological) $136.36
- DERMATITIS - DISEASE (Drug) $105.97
- STELARA (Biological) $104.85
- AKLIEF (Drug) $87.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Atlanta
Melhem Solh, M.d, M.D
Specialist — Payments: $1.1M
Sumayah Taliaferro, Md, MD
Specialist — Payments: $98,474
Theresa Jarmuz, M.d, M.D
Specialist — Payments: $98,072
Dr. Scott Solomon, M.d, M.D
Specialist — Payments: $59,894
Dr. Asad Bashey, M.d, M.D
Specialist — Payments: $45,487
Dr. Bronier Costas, M.d, M.D
Specialist — Payments: $45,325